repository
BROWSE
Cited 0 times in 
Harnessing SARS-CoV-2-specific CD8+ T cells to kill target tumor cells for cancer immunotherapy
- Citation
- Cancer communications (London, England), 44(1). : 173-177, 2024
- Journal Title
- Cancer communications (London, England)
- ISSN
- 2523-3548
- PMID
- 37856250
- Appears in Collections:
- Journal Papers > Hospital > Clinical Trial Center
Journal Papers > School of Medicine / Graduate School of Medicine > Infectious Diseases
- Full Text Link
- Files in This Item:
- 37856250.pdfDownload
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
-
- License
